Paricalcitol Accelerates BACE1 Lysosomal Degradation and Inhibits Calpain-1 Dependent Neuronal Loss in APP/PS1 Transgenic Mice
Overview
Authors
Affiliations
Background: Recent studies have revealed that vitamin D deficiency may increase the risk of Alzheimer's disease, and vitamin D supplementation may be effective strategy to ameliorate the neurodegenerative process in Alzheimer's disease patients. Paricalcitol (PAL), a low-calcemic vitamin D receptor agonist, is clinically used to treat secondary hyperparathyroidism. However, the potential application of PAL for treating neurodegenerative disorders remains unexplored.
Methods: The APP/PS1 mice were intraperitoneally injected with PAL or vehicle every other day for 15 weeks. The β-amyloid (Aβ) production was confirmed using immunostaining and enzyme linked immunosorbent assay. The underlying mechanism was verified by western blot and immunostaining in vivo and in vitro.
Findings: Long-term PAL treatment clearly reduced β-amyloid (Aβ) generation and neuronal loss in APP/PS1 transgenic mouse brains. PAL stimulated the expression of low-density lipoprotein receptor-related protein 1 (LRP1) possibly through inhibiting sterol regulatory element binding protein-2 (SREBP2); PAL also promoted LRP1-mediated β-site APP cleavage enzyme 1 (BACE1) transport to late endosomes, thus increasing the lysosomal degradation of BACE1. Furthermore, PAL diminished 8-hydroxyguanosine (8-OHdG) generation in neuronal mitochondria via enhancing base excision repair (BER), resulting in the attenuation of calpain-1-mediated neuronal loss.
Interpretation: The present data demonstrate that PAL can reduce Aβ generation through accelerating BACE1 lysosomal degradation and can inhibit neuronal loss through suppressing mitochondrial 8-OHdG generation. Hence, PAL might be a promising agent for treating Alzheimer's disease. FUND: This study was financially supported by the Natural Science Foundation of China (U1608282).
He D, Zhang X, Su J, Zhang Q, Zhao L, Wu T Aging Cell. 2024; 24(1):e14336.
PMID: 39287420 PMC: 11709109. DOI: 10.1111/acel.14336.
The Role of Endophilin A1 in Lipopolysaccharide-Induced Parkinson's Disease Model Mice.
Han J, Liu M, Ling Y, Ren Y, Qiu Y, Liu Y J Parkinsons Dis. 2023; 13(5):743-756.
PMID: 37334616 PMC: 10473136. DOI: 10.3233/JPD-225098.
Thiel A, Hermanns C, Lauer A, Reichrath J, Erhardt T, Hartmann T Nutrients. 2023; 15(7).
PMID: 37049524 PMC: 10096957. DOI: 10.3390/nu15071684.
Lason W, Jantas D, Leskiewicz M, Regulska M, Basta-Kaim A Cells. 2023; 12(4).
PMID: 36831327 PMC: 9954016. DOI: 10.3390/cells12040660.
He D, Fan Y, Wang Z Curr Neuropharmacol. 2022; 21(1):67-86.
PMID: 35980072 PMC: 10193753. DOI: 10.2174/1570159X20666220817140737.